Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase Incidences of Chronic Diseases, Road Accidents, and Trauma Injuries
4.2.2 Technological Advancements in 3D Tissue Engineering
4.2.3 Increase in Funding and Research for Tissue Regeneration
4.3 Market Restraints
4.3.1 High Cost of Treatments Related to Tissue Engineering
4.3.2 Lack of Awareness Regarding Tissue Engineering
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Material
5.1.1 Synthetic Materials
5.1.2 Biologically Derived Materials
5.1.3 Others
5.2 By Application
5.2.1 Orthopedics
5.2.2 Musculoskeletal & Spine
5.2.3 Neurology
5.2.4 Cardiology & Vascular
5.2.5 Skin & Integumentary
5.2.6 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AbbVie Inc. (Allergan)
6.1.2 Integra Lifesciences
6.1.3 Becton, Dickinson and Company (C. R. Bard)
6.1.4 Zimmer Biomet
6.1.5 Organogenesis
6.1.6 Osiris Therapeutics
6.1.7 Biotime Inc.
6.1.8 B. Braun Melsungen AG
6.1.9 Bio Tissue Technologies


7 MARKET OPPORTUNITIES AND FUTURE TRENDS